Farther Finance Advisors’s Beta Bionics BBNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.85K Sell
309
-62
-17% -$737 ﹤0.01% 4820
2026
Q1
$3.71K Buy
371
+79
+27% +$1.17K ﹤0.01% 4638
2025
Q4
$8.9K Buy
292
+2
+0.7% +$53 ﹤0.01% 3992
2025
Q3
$5.76K Hold
290
﹤0.01% 3696
2025
Q2
$4.22K Buy
+290
New +$4.11K ﹤0.01% 3425

Other funds holding BBNX

Farther Finance Advisors's BBNX Position: Q2 2026 in Review

Farther Finance Advisors reduced its Beta Bionics (BBNX) stake by 17% in Q2 2026, selling an estimated $737 and leaving 309 shares worth $4.85K. The position accounts for ﹤0.01% of the portfolio, ranked #4820.

Farther Finance Advisors first reported a position in BBNX in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.9K in Q4 2025. 19 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Farther Finance Advisors held 309 shares of Beta Bionics worth $4.85K as of Q2 2026.
  • Farther Finance Advisors sold 62 Beta Bionics shares in Q2 2026, an estimated $737.
  • Beta Bionics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4820 holding.
  • Farther Finance Advisors first reported a position in Beta Bionics in Q2 2025 and has held it in 5 quarters since.
  • Farther Finance Advisors's Beta Bionics position peaked at $8.9K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.